We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead.
European urology. 2019 May 23 [Epub ahead of print]
Matthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, Benjamin J Davies, John W Davis, Scott E Eggener, Felix Y Feng, Daniel W Lin, Todd M Morgan, Alicia K Morgans, Daniel E Spratt, Samir S Taneja, David F Penson
Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA. Electronic address: ., Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Department of Urology, University of California, Davis, Sacramento, CA, USA., Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., MD Anderson Cancer Center, Houston, TX, USA., Department of Surgery, University of Chicago, Chicago, IL, USA., Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Radiation Oncology, University of California, San Francisco, CA, USA., Department of Urology, University of Washington and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., University of Michigan Department of Urology, Ann Arbor, MI, USA., Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI, USA., NYU Langone Health, New York, NY, USA., Department of Urology, Vanderbilt University School of Medicine, Nashville, TN, USA; Tennessee Valley Health Care System, Nashville, TN, USA.